EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo

Antiviral Research

Volumn 94, Issue 2, 2012, Pages 147-156

  Theisen, Linda L ^a   Muller, Claude P ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Antiviral; Gallocatechin; Influenza A virus; Pelargonium sidoides; Polyphenol; Prodelphinidin

Indexed keywords

ANTIVIRUS AGENT; DIMER; EPIGALLOCATECHIN; GALLOCATECHIN; MONOMER; OLIGOMER; PELARGONIUM SIDOIDES EXTRACT; UMCKALOABO; VIRUS SIALIDASE;

ADENOVIRUS; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MEASLES VIRUS; NONHUMAN; PARTICLE SIZE; PLANT ROOT; PRIORITY JOURNAL; PROVOCATION TEST; SURVIVAL; VIRUS HEMAGGLUTINATION; WEIGHT REDUCTION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BODY TEMPERATURE; BODY WEIGHT; FEMALE; HEMAGGLUTINATION, VIRAL; INFLUENZA A VIRUS; MEASLES VIRUS; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PELARGONIUM; PLANT EXTRACTS; PLANT ROOTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADENOVIRIDAE; INFLUENZA A VIRUS; MEASLES VIRUS; MUS; ORTHOMYXOVIRIDAE; PELARGONIUM SIDOIDES;

EID: 84860274597     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.03.006     Document Type: Article

References (57)

1. Agbabiaka T.B., Guo R., Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine 2008, 15:378-385.
2. Beil W., Kilian P. EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells. Phytomedicine 2007, 14(Suppl. 6):5-8.
3. Brendler T., van Wyk B.E. A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). J. Ethnopharmacol. 2008, 119:420-433.
4. Centers for Disease Control and Prevention (CDC), 2009. Update: Influenza activity-United States, September 28, 2008-January 31, 2009. MMWR Morb. Mortal. Wkly. Rep. 58, 115-119.
5. Cheng H.Y., Lin C.C., Lin T.C. Antiviral properties of prodelphinidin B-2 3'-O-gallate from green tea leaf. Antivir. Chem. Chemother. 2002, 13:223-229.
6. Conrad A., Kolodziej H., Schulz V. Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety. Wien. Med. Wochenschr. 2007, 157:331-336.
7. De Bruyne T., Pieters L., Witvrouw M., De Clercq E., Vanden Berghe D., Vlietinck A.J. Biological evaluation of proanthocyanidin dimers and related polyphenols. J. Nat. Prod. 1999, 62:954-958.
8. Deprez S., Mila I., Huneau J.F., Tome D., Scalbert A. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid. Redox Signal 2001, 3:957-967.
9. Dittmann J., Stertz S., Grimm D., Steel J., Garcia-Sastre A., Haller O., Kochs G. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 2008, 82:3624-3631.
10. Droebner K., Ehrhardt C., Poetter A., Ludwig S., Planz O. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 2007, 76:1-10.
11. Ehrhardt C., Hrincius E.R., Korte V., Mazur I., Droebner K., Poetter A., Dreschers S., Schmolke M., Planz O., Ludwig S. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res. 2007, 76:38-47.
12. Erdelmeier C.A., Cinatl J., Rabenau H., Doerr H.W., Biber A., Koch E. Antiviral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med. 1996, 62:241-245.
13. Fink R.C., Roschek B., Alberte R.S. HIV type-1 entry inhibitors with a new mode of action. Antivir. Chem. Chemother. 2009, 19:243-255.
14. Fiore A.E., Fry A., Shay D., Gubareva L., Bresee J.S., Uyeki T.M. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2011, 60:1-24.
15. Gescher K., Hensel A., Hafezi W., Derksen A., Kühn J. Oligomeric proanthocyanidins from Rumex acetosa L. inhibit the attachment of herpes simplex virus type-1. Antiviral Res. 2011, 89:9-18.
16. Gescher K., Kühn J., Lorentzen E., Hafezi W., Derksen A., Deters A., Hensel A. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J. Ethnopharmacol. 2011, 134:468-474.
17. Hagerman A.E., Butler L.G. The specificity of proanthocyanidin-protein interactions. J. Biol. Chem. 1981, 256:4494-4497.
18. Haidari M., Ali M., Ward Casscells S., Madjid M. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine 2009, 16:1127-1136.
19. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89:2359-2376.
20. Hayden F.G., de Jong M.D. Emerging influenza antiviral resistance threats. J. Infect. Dis. 2011, 203:6-10.
21. Ho H.Y., Cheng M.L., Weng S.F., Leu Y.L., Chiu D.T. Antiviral effect of epigallocatechin gallate on enterovirus 71. J. Agric. Food Chem. 2009, 57:6140-6147.
22. Howell A.B., Vorsa N., Der Marderosian A., Foo L.Y. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N. Engl. J. Med. 1998, 339:1085-1086.
23. Hurt A.C., Hardie K., Wilson N.J., Deng Y.M., Osbourn M., Gehrig N., Kelso A. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N. Engl. J. Med. 2011, 365:2541-2542.
24. Jackson R.J., Cooper K.L., Tappenden P., Rees A., Simpson E.L., Read R.C., Nicholson K.G. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. J. Infect. 2011, 62:14-25.
25. Janecki A., Kolodziej H. Anti-adhesive activities of flavan-3-ols and proanthocyanidins in the interaction of group A-streptococci and human epithelial cells. Molecules 2010, 15:7139-7152.
26. Janecki A., Conrad A., Engels I., Frank U., Kolodziej H. Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs® 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells. J. Ethnopharmacol. 2010, 133:147-152.
27. Jefferson T., Jones M., Doshi P., Del Mar C. Possible harms of oseltamivir - a call for urgent action. Lancet 2009, 374:1312-1313.
28. Kamin W., Maydannik V., Malek F.A., Kieser M. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int. J. Clin. Pharmacol. Ther. 2010, 48:184-191.
29. Kittel C., Sereinig S., Ferko B., Stasakova J., Romanova J., Wolkerstorfer A., Katinger H., Egorov A. Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 2004, 324:67-73.
30. Kolodziej H., Kiderlen A.F. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630. Phytomedicine 2007, 14(Suppl. 6):18-26.
31. Kolodziej H., Kayser O., Radtke O.A., Kiderlen A.F., Koch E. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 2003, 10(Suppl. 4):18-24.
32. Ludwig S., Wolff T., Ehrhardt C., Wurzer W.J., Reinhardt J., Planz O., Pleschka S. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett. 2004, 561:37-43.
33. Matheson, N.J., Harnden, A.R., Perera, R., Sheikh, A., Symmonds-Abrahams, M., 2007. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst. Rev., CD002744.
34. Matthys H., Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr. Med. Res. Opin. 2007, 23:323-331.
35. Matthys H., Eisebitt R., Seith B., Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 2003, 10(Suppl. 4):7-17.
36. Michaelis M., Doerr H.W., Cinatl J. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine 2010, 18:384-386.
37. Nakamura K., Schwartz B.S., Lindegardh N., Keh C., Guglielmo B.J. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin. Infect. Dis. 2010, 50:e47-49.
38. Oldham M.J., Robinson R.J. Predicted tracheobronchial and pulmonary deposition in a murine asthma model. Anat. Rec. (Hoboken) 2007, 290:1309-1314.
39. Pastene E., Speisky H., Garcia A., Moreno J., Troncoso M., Figueroa G. In vitro and in vivo effects of apple peel polyphenols against Helicobacter pylori. J. Agric. Food. Chem. 2010, 58:7172-7179.
40. Pleschka S., Stein M., Schoop R., Hudson J.B. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol. J. 2009, 6:197.
41. Raabe O.G., Al-Bayati M.A., Teague S.V., Rasolt A. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Inhaled Particles VI 1988, 53-63. Pergamon Press, Oxford.
42. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22:659-661.
43. Rimmelzwaan G.F., Baars M.M., de Lijster P., Fouchier R.A., Osterhaus A.D. Inhibition of influenza virus replication by nitric oxide. J. Virol. 1999, 73:8880-8883.
44. Schnitzler P., Schneider S., Stintzing F.C., Carle R., Reichling J. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus. Phytomedicine 2008, 15:1108-1116.
45. Schoetz K., Erdelmeier C., Germer S., Hauer H. A detailed view on the constituents of EPs 7630. Planta Med. 2008, 74:667-674.
46. Schötz K., Nöldner M. Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models. Phytomedicine 2007, 14(Suppl. 6):32-39.
47. Shahat A.A., Cos P., De Bruyne T., Apers S., Hammouda F.M., Ismail S.I., Azzam S., Claeys M., Goovaerts E., Pieters L., Vanden Berghe D., Vlietinck A.J. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med. 2002, 68:539-541.
48. Sheu T.G., Fry A.M., Garten R.J., Deyde V.M., Shwe T., Bullion L., Peebles P.J., Li Y., Klimov A.I., Gubareva L.V. Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. J. Infect. Dis. 2011, 203:13-17.
49. Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005, 68:66-74.
50. Spencer J.P., Chaudry F., Pannala A.S., Srai S.K., Debnam E., Rice-Evans C. Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 2000, 272:236-241.
51. Sundararajan A., Ganapathy R., Huan L., Dunlap J.R., Webby R.J., Kotwal G.J., Sangster M.Y. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 2010, 88:1-9.
52. Takechi M., Tanaka Y., Takehara M., Nonaka G., Nishioka I. Structure and antiherpetic activity among the tannins. Phytochemistry 1985, 24:2245-2250.
53. Thäle C., Kiderlen A.F., Kolodziej H. Anti-infective activities of Pelargonium sidoides (EPS(R) 7630): effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay. Planta Med. 2011, 77:718-725.
54. Vennat B., Gross D., Pourrat H. Hamamelis virginiana: identification and assay of proanthocyanidins, phenolic acids and flavonoids in leaf extracts. Pharm. Acta Helv. 1992, 67:11-14.
55. Wittschier N., Faller G., Hensel A. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach. Phytomedicine 2007, 14:285-288.
56. Yang C.S., Lee M.J., Chen L. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol. Biomarkers Prev. 1999, 8:83-89.
57. Zhu M., Phillipson J.D., Greengrass P.M., Bowery N.E., Cai Y. Plant polyphenols: biologically active compounds or non-selective binders to protein?. Phytochemistry 1997, 44:441-447.